Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.

Clinical chemistry - 1 Oct 2006

Popov Joanna, Zhukov Olga, Ruden Susan, Zeschmann Terry, Sferruzza Anthony, Sahud Mervyn

Abstract excerpt

BACKGROUND: Von Willebrand disease (VWD) diagnosis and classification usually require a combination of nonspecific and VW-factor (VWF)-specific assays. We evaluated the analytical performance of a commercially available collagen-binding assay (CBA) and its usefulness in conjunction with other assays for laboratory diagnosis of VWD. METHODS: We used a commercial CBA ELISA (Life Technologies) to evaluate 3085...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Collagen
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Protein Binding

Share to Reference Values

Share to Reproducibility of Results

Share to von Willebrand Diseases

Share to von Willebrand Factor

Source

Identifiers

PMID: 16887898
DOI: 10.1373/clinchem.2006.070730

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.PMID 16887898Read ↗

Critical von Willebrand factor A1 domain residues influence type VI collagen binding.Semantic proximity Read ↗

Advances in the diagnosis and treatment of Von Willebrand disease.Semantic proximity Read ↗

Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.Semantic proximity Read ↗

Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.Semantic proximity Read ↗

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?Semantic proximity Read ↗

Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.Semantic proximity Read ↗

Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents.Semantic proximity Read ↗

Type 2N von Willebrand disease: Characterization and diagnostic difficulties.Semantic proximity Read ↗

Rapid discrimination of the phenotypic variants of von Willebrand disease.Semantic proximity Read ↗

The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.Semantic proximity Read ↗

Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.Semantic proximity Read ↗

Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.